Pharma Marketer (@pharma_marketer) profile picture

Pharma Marketer

@pharma_marketer

Your premier resource for conference-quality pharma content and connections without the travel. Contributors welcome. Tweeted by our Community Management team.

 The Pharmaceutical Corridor
pharma-marketer.com
Joined May 2009
  • Tweets15.3K
  • Following2.2K
  • Followers4.6K
FDA Pulls Wolfe Off Panel Over ‘Intellectual’ Conflict bit.ly/sKPtDp
3
5
Novartis: No More Neuroscience bit.ly/rrWNRY
1
Novartis joins exodus from traditional R&D neuroscience drug work bit.ly/vCiOj3
2
1
Ranbaxy CEO: Generic Lipitor Was ‘A Thriller’ bit.ly/vyauK7
1
Protalix shares dive on Gaucher’s drug delay at FDA bit.ly/tUaOYt
Consumers Want Info From Websites, Not Facebook bit.ly/uUGBdy
1
Sanofi adds to growing cache of positive PhIII lixisenatide data bit.ly/tYfnfj
GSK’s new R&D culture forces research chiefs to hustle for support bit.ly/rxiqw2
1
Merck blueprints Asian R&D HQ in Beijing in $1.5B research blitz bit.ly/voEkxa
Should FTC OK The Express Scripts-Medco Deal? bit.ly/t3nlvP
Biogen Idec signs up with Samsung on $300 million biosimilars venture bit.ly/t428zK
Be Aware of What’s Behind a Pharma Mobile App: Disclaimers Only Tell Part of the Story bit.ly/uHtuyX
2
1
Riding to the Rescue of Rhodanines bit.ly/w0vgSm
Alzheimer’s Disease and Boomers fears bit.ly/ryKv4A
False Claims Probe Did Not Stop Off-Label Marketing bit.ly/tJqAtq
Former FDA Commish: Bayer Hid Yasmin Data bit.ly/tax9Dv
1
USA: Victrelis – “To move forward” print ad bit.ly/sINQkw
Risk for Dementia Rises When Diabetes, Depression Meet: Study (HealthDay) bit.ly/vmXWPI
Pfizer cancer drug effect may be limited: FDA staff (Reuters) bit.ly/rPJfXe
Could acute postpartum blues signal bipolar disorder? (Reuters) bit.ly/v5alJa
Load more